Dexcom (DXCM) Inventory (2010 - 2026)

Dexcom (DXCM) has reported Inventory for 17 consecutive years, with $726.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Inventory rose 27.28% year-over-year to $726.4 million in Q2 2026; TTM through Jun 2026 was $726.4 million, a 27.28% increase from a year earlier, with the FY2025 full-year figure at $629.1 million, up 15.94% from the prior year.
• Inventory was $726.4 million for Q2 2026 at Dexcom, up from $693.6 million in the prior quarter.
• Over five years, Inventory peaked at $726.4 million in Q2 2026 and troughed at $306.7 million in Q4 2022.
• A 5-year average of $510.8 million and a median of $551.1 million in 2023 frame the typical range for Inventory.
• Across the five-year window, Inventory retreated 14.16% in 2022 and surged 82.46% in 2023, its largest moves.
• Over 5 years, Inventory stood at $306.7 million in 2022, then jumped by 82.46% to $559.6 million in 2023, then decreased by 3.04% to $542.6 million in 2024, then grew by 15.94% to $629.1 million in 2025, then rose by 15.47% to $726.4 million in 2026.
• The last three Inventory figures came in at $726.4 million (Q2 2026), $693.6 million (Q1 2026), and $629.1 million (Q4 2025), per Business Quant data.